B cells have been shown to be effective for predicting which cancer patients will respond to immune checkpoint blockade therapy, according to a study at MD Anderson Cancer Center. Study results will be presented April 2 at the AACR Annual Meeting 2019 in Atlanta.
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
